|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001721,
umls-concept:C0007634,
umls-concept:C0009324,
umls-concept:C0079189,
umls-concept:C0162638,
umls-concept:C0214743,
umls-concept:C0221908,
umls-concept:C0242358,
umls-concept:C0680635,
umls-concept:C1554080,
umls-concept:C1706198
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-8-8
|
|
pubmed:abstractText |
Ulcerative colitis (UC) is characterized by a Th2 immune response with inflammation and epithelial barrier dysfunction. So far, Th2 cytokines have not been shown to directly influence epithelial barrier function.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
pubmed-author:BürgelNatalyN,
pubmed-author:BojarskiChristianC,
pubmed-author:ChristMelanieM,
pubmed-author:FlorianPeterP,
pubmed-author:FrommMichaelM,
pubmed-author:FussIvanI,
pubmed-author:GitterAlfred HAH,
pubmed-author:HellerFrankF,
pubmed-author:HillenbrandBerndB,
pubmed-author:MankertzJoachimJ,
pubmed-author:RichterJanJ,
pubmed-author:SchulzkeJörg DJD,
pubmed-author:StroberWarrenW,
pubmed-author:ZeitzMartinM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
129
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
550-64
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16083712-Adult,
pubmed-meshheading:16083712-Apoptosis,
pubmed-meshheading:16083712-Biological Markers,
pubmed-meshheading:16083712-Biopsy, Needle,
pubmed-meshheading:16083712-Blotting, Western,
pubmed-meshheading:16083712-Cell Proliferation,
pubmed-meshheading:16083712-Cells, Cultured,
pubmed-meshheading:16083712-Colitis, Ulcerative,
pubmed-meshheading:16083712-Crohn Disease,
pubmed-meshheading:16083712-Cytokines,
pubmed-meshheading:16083712-Epithelial Cells,
pubmed-meshheading:16083712-Female,
pubmed-meshheading:16083712-Humans,
pubmed-meshheading:16083712-Immunohistochemistry,
pubmed-meshheading:16083712-Interleukin-13,
pubmed-meshheading:16083712-Intestinal Mucosa,
pubmed-meshheading:16083712-Male,
pubmed-meshheading:16083712-Middle Aged,
pubmed-meshheading:16083712-Probability,
pubmed-meshheading:16083712-Prognosis,
pubmed-meshheading:16083712-Risk Factors,
pubmed-meshheading:16083712-Sampling Studies,
pubmed-meshheading:16083712-Sensitivity and Specificity,
pubmed-meshheading:16083712-Th2 Cells,
pubmed-meshheading:16083712-Tight Junctions
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
|
|
pubmed:affiliation |
Department of Gastroenterology, Charité, Campus Benjamin Franklin, Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
